The induction of E47 activity was sufficient to inhibit tumor growth in ovarian cancer cells in vitro, therefore we hypothesized that altering the bHLH transcription networks might also inhibit tumor growth of ovarian cancer cells in vivo. The gene discussed is TCF3; the disease is neoplasm.